Drooping Eyelids? Discover How Upneeq Can Help
Ptosis, or drooping eyelids, is quite common, especially among older individuals. But that doesn’t mean you can’t do anything about it. Thankfully, there are treatments for the few that develop it in early life, as well as the many whose eyelids slowly begin to droop as they age.
Let’s take a closer look at ptosis and its various causes, as well as Upneeq, an incredible treatment specifically designed to combat this condition.
What is Ptosis?
Ptosis is the medical term for drooping eyelids, and it can occur in one or both eyes. There are three main causes of ptosis:
- Damage to the nerves that control the eyelid
- Weakness in the muscle that raises the eyelid
- Loose skin in the upper eyelid
Ptosis can affect people of all ages, but becomes more prevalent in old age, as the muscles in the eyelid stretch and weaken.
Ptosis can range from minor to severe, with minor ptosis sometimes being difficult to detect (and not being a significant issue), while severe ptosis can lead to the eyelid drooping over the eye and obscuring vision.
Fortunately, we offer an excellent treatment for acquired ptosis: Upneeq eyedrops.
What is Upneeq?
Upneeq is an FDA-approved prescription eyedrop that is designed specifically to treat ptosis by lifting the upper eyelid.
Upneeq produces significant results with little to no side effects. In clinical trials, 84% of patients saw some form of improvement with their ptosis. One study showed that some patients even saw relief of their condition within two hours of receiving a dose of Upneeq.
Studies have also indicated that:
- 87.8% of patients had some form of improvement
- 40.8% of patients had at least a 50% improvement on Day 14 (two hours after applying Upneeq)
These trials also proved that Upneeq is safe when used as directed by a medical professional.
If you are looking for a treatment for your ptosis, look no further than Upneeq. It is a safe, reliable, and effective treatment for drooping eyelids. Call us to learn if Upneeq is right for you.